EUVIMEDOpdag EUVIMED
Open access · CC BY 4.0

Should the use of omeprazole be allowed during equestrian competition?

Madeleine L H Campbell iD, Benjamin W Sykes iD

Equine Veterinary Journal · 2025

DOI: 10.1111/evj.14129 ↗

At a glance

Journal article in Equine Veterinary Journal, 2025. Written by Madeleine L H Campbell and 1 co-authors. Institution: School of Veterinary Medicine and Science, University of Nottingham, Loughborough, UK. Major MEDLINE topics: Omeprazole, Sports, Horse Diseases, Animal Welfare. Cited 2 times so far (Crossref); 26 references. The full text is freely available (open access, CC BY 4.0). Funded by: World Horse Welfare.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background

Prioritising equine welfare, making evidenced‐based policy, and consistent decision‐making across sports are crucial to maintaining the social licence for equestrian sport. Regulations on the use of omeprazole during competition differ; all regulators argue that their rules prioritise welfare. This discrepancy is a matter of concern to the public and equestrian stakeholders.

Objectives

To apply Campbell's Ethical Framework for the use of Horses in Sport to the question: ‘Should the use of omeprazole be allowed during equestrian competition?’ Study design A desk‐based ethico‐legal study.

Methods

Campbell's Ethical Framework for the Use of Horses in Sport was applied in a stepwise fashion: definition of the ethical question; analysis of the evidence base; consideration of stakeholders' interests; harm:benefit analysis; application of the three central tenets of the framework, and formulation of conclusions and recommendations.

Results

Stakeholders in equine sports have a variety of (frequently conflicting) interests; all of them share an interest in optimising equine welfare. The incidence of EGUS in competition horses is high. Omeprazole is a cornerstone treatment. There are currently discrepancies in regulation about the use of omeprazole during competitions. Recent evidence suggests that withholding omeprazole treatment for two clear days before competition allows the recurrence of squamous EGUS, whereas withholding treatment on the day of competition only does not have that effect. Main limitations The current state of scientific knowledge about the use of omeprazole in horses. The analysis did not consider possible health and thus welfare effects of the out‐of‐competition treatment with omeprazole.

Conclusions

Based on recent scientific evidence, if horses are being treated with omeprazole outside of competition then treatment on the day of competition should be permitted on welfare grounds. Revision of regulations around the use of omeprazole during competition by governing bodies is necessary to safeguard the ethical use of horses in sport.

Subjects

MeSH terms (MEDLINE)

OmeprazoleSportsHorse DiseasesAnimal WelfareAnti-Ulcer AgentsPhysical Conditioning, AnimalAnimalsHorses

Author keywords

competitionethicshorseomeprazolesocial licencewelfare

Substances

OmeprazoleAnti-Ulcer Agents

Authors and institutions

  • School of Veterinary Medicine and Science, University of Nottingham, Loughborough, UK.
  • School of Veterinary Sciences, Massey University, Palmerston North, New Zealand.

ORCID profiles: Madeleine L H Campbell, Benjamin W Sykes

Funding

  • World Horse Welfare

Cite

APA

Campbell, M. L. H., & Sykes, B. W. (2025). Should the use of omeprazole be allowed during equestrian competition?. Equine Veterinary Journal. https://doi.org/10.1111/evj.14129

Vancouver

Campbell MLH, Sykes BW. Should the use of omeprazole be allowed during equestrian competition?. Equine Veterinary Journal. 2025. doi:10.1111/evj.14129

BibTeX
@article{Campbell2025,
  author = {Campbell, Madeleine L H and Sykes, Benjamin W},
  title = {Should the use of omeprazole be allowed during equestrian competition?},
  journal = {Equine Veterinary Journal},
  year = {2025},
  doi = {10.1111/evj.14129}
}
Start for free →